Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Unmet need for referred services as measured by general practice.

McGeoch G, Holland K, Kerdemelidis M, Elliot N, Shand B, Fink C, Dixon A, Gullery C.

J Prim Health Care. 2017 Dec;9(4):269-278. doi: 10.1071/HC17044.

PMID:
29530138
2.

Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit.

Swann R, McPhail S, Witt J, Shand B, Abel GA, Hiom S, Rashbass J, Lyratzopoulos G, Rubin G; National Cancer Diagnosis Audit Steering Group.

Br J Gen Pract. 2018 Jan;68(666):e63-e72. doi: 10.3399/bjgp17X694169. Epub 2017 Dec 18.

3.

Development and outcomes of a primary care-based sleep assessment service in Canterbury, New Zealand.

Epton MJ, Kelly PT, Shand BI, Powell SV, Jones JN, McGeoch GRB, Hlavac MC.

NPJ Prim Care Respir Med. 2017 Apr 19;27(1):26. doi: 10.1038/s41533-017-0030-1.

4.

Does the addition of saline infusion sonohysterography to transvaginal ultrasonography prevent unnecessary hysteroscopy in premenopausal women with abnormal uterine bleeding?

Short J, Sharp B, Elliot N, McEwing R, McGeoch G, Shand B, Holland K.

Aust N Z J Obstet Gynaecol. 2016 Aug;56(4):432-5. doi: 10.1111/ajo.12490. Epub 2016 Jul 1.

PMID:
27363343
5.

Management of postmenopausal bleeding by general practitioners in a community setting: an observational study.

Stravens M, Langdana F, Short J, Johnson K, Simcock B, Shand B, McGeoch G, Sykes P.

N Z Med J. 2016 May 6;129(1434):59-68.

PMID:
27349264
6.

Medication overuse headache in Europe and Latin America: general demographic and clinical characteristics, referral pathways and national distribution of painkillers in a descriptive, multinational, multicenter study.

Find NL, Terlizzi R, Munksgaard SB, Bendtsen L, Tassorelli C, Nappi G, Katsarava Z, Lainez M, Goicochea MT, Shand B, Fadic R, Spadafora S, Pagani M, Jensen R; COMOESTAS Consortium.

J Headache Pain. 2015;17:20. doi: 10.1186/s10194-016-0612-2. Epub 2016 Mar 8.

7.

A regional programme to improve skin cancer management.

McGeoch GR, Sycamore MJ, Shand BI, Simcock JW.

J Prim Health Care. 2015 Dec 1;7(4):339-44.

PMID:
26668840
8.

Clinical and Demographical Characteristics of Patients with Medication Overuse Headache in Argentina and Chile: Analysis of the Latin American Section of COMOESTAS Project.

Shand B, Goicochea MT, Valenzuela R, Fadic R, Jensen R, Tassorelli C, Nappi G; COMOESTAS CONSORTIUM.

J Headache Pain. 2015;16:83. doi: 10.1186/s10194-015-0561-1. Epub 2015 Sep 18.

9.

HealthPathways: some clarification.

McGeoch G, Shand B.

N Z Med J. 2015 Apr 17;128(1412):65-6. No abstract available.

PMID:
25899496
10.

The development of a community-based spirometry service in the Canterbury region of New Zealand: observations on new service delivery.

Epton MJ, Stanton JD, McGeoch GR, Shand BI, Swanney MP.

NPJ Prim Care Respir Med. 2015 Mar 5;25:15003. doi: 10.1038/npjpcrm.2015.3.

11.

Consensus pathways: evidence into practice.

McGeoch G, Anderson I, Gibson J, Gullery C, Kerr D, Shand B.

N Z Med J. 2015 Jan 30;128(1408):86-96.

PMID:
25662382
12.
13.

[Survey on moral judgment criteria among medical students].

Bedregal P, León T, Shand B, Mosso L.

Rev Med Chil. 2013 Jun;141(6):704-9. doi: 10.4067/S0034-98872013000600003. Spanish.

14.

Hydration and nutrition at the end of life: a systematic review of emotional impact, perceptions, and decision-making among patients, family, and health care staff.

Del Río MI, Shand B, Bonati P, Palma A, Maldonado A, Taboada P, Nervi F.

Psychooncology. 2012 Sep;21(9):913-21. doi: 10.1002/pon.2099. Epub 2011 Dec 8. Review.

PMID:
22162174
15.

What is the best predictor of the atherogenic LDL subclass phenotype 'pattern B' in patients with type 2 diabetes mellitus?

King RI, Florkowski CM, Yeo J, Walmsley TA, Shand BI, Scott RS, George PM.

Ann Clin Biochem. 2011 Mar;48(Pt 2):166-9. doi: 10.1258/acb.2010.010185. Epub 2011 Jan 28.

PMID:
21278248
16.

Fibrates plus betaine: a winning combination?

Lever M, George PM, Slow S, Elmslie JL, Shand BI, Scott RS, Chambers ST.

N Z Med J. 2010 Oct 15;123(1324):74-8. Review.

PMID:
20953225
17.

[Contribution of epigenetics to understand human development].

Bedregal P, Shand B, Santos MJ, Ventura-Juncá P.

Rev Med Chil. 2010 Mar;138(3):366-72. doi: /S0034-98872010000300018. Epub 2010 May 19. Review. Spanish.

18.

Plasma sex hormone-binding globulin, corticosteroid-binding globulin, cortisol, and free cortisol levels in outpatients attending a lipid disorders clinic: a cross-sectional study of 1137 subjects.

Lewis JG, Borowski KK, Shand BI, George PM, Scott RS.

Horm Metab Res. 2010 Apr;42(4):274-9. doi: 10.1055/s-0029-1243260. Epub 2010 Jan 7.

PMID:
20354921
19.

[Ethical problems in medical services from the patients' point of view].

León T, Bedregal P, Shand B.

Rev Med Chil. 2009 Jun;137(6):759-65. doi: /S0034-98872009000600005. Epub 2009 Sep 4. Spanish.

20.

Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.

Shand BI, Scott RS, Lewis JG, Elder PA, Frampton CM.

Int J Obes (Lond). 2009 Nov;33(11):1274-9. doi: 10.1038/ijo.2009.169. Epub 2009 Sep 1.

PMID:
19721448
21.

Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.

Elmslie JL, Porter RJ, Joyce PR, Hunt PJ, Shand BI, Scott RS.

Aust N Z J Psychiatry. 2009 Jan;43(1):53-60. doi: 10.1080/00048670802534341.

PMID:
19085528
22.

Plasma levels of sex hormone-binding globulin, corticosteroid-binding globulin and cortisol in overweight subjects who develop impaired fasting glucose: a 3-year prospective study.

Lewis JG, Shand BI, Frampton CM, Elder PA, Scott RS.

Horm Metab Res. 2009 Mar;41(3):255-9. doi: 10.1055/s-0028-1087190. Epub 2008 Oct 23.

PMID:
18949680
23.

Plasma retinol-binding protein is not a marker of insulin resistance in overweight subjects: a three year longitudinal study.

Lewis JG, Shand BI, Frampton CM, Elder PA, Scott RS.

Clin Biochem. 2008 Sep;41(13):1034-8. doi: 10.1016/j.clinbiochem.2008.06.002. Epub 2008 Jun 13.

PMID:
18588869
24.

Adiponectin attenuates endothelial dysfunction induced by oxidised low-density lipoproteins.

Plant S, Shand B, Elder P, Scott R.

Diab Vasc Dis Res. 2008 Jun;5(2):102-8. doi: 10.3132/dvdr.2008.017.

PMID:
18537097
25.

Plasma retinol-binding protein is unlikely to be a useful marker of insulin resistance.

Lewis JG, Shand BI, Elder PA, Scott RS.

Diabetes Res Clin Pract. 2008 Apr;80(1):e13-5. doi: 10.1016/j.diabres.2007.12.002. Epub 2008 Jan 14.

PMID:
18194820
26.

Comparison of plasma adiponectin levels in New Zealand Maori and Caucasian individuals.

Shand B, Elder P, Scott R, Poa N, Frampton CM.

N Z Med J. 2007 Jun 29;120(1257):U2606.

PMID:
17632596
27.

Comparative study on the efficacy of pioglitazone in Caucasian and Maori-Polynesian patients with poorly controlled type 2 diabetes.

Shand B, Scott R, Connolly S, Clarke R, Baker J, Elder P, Frampton C, Yeo J.

Diabetes Obes Metab. 2007 Jul;9(4):540-7.

PMID:
17587396
28.

An ELISA for plasma retinol-binding protein using monoclonal and polyclonal antibodies: plasma variation in normal and insulin resistant subjects.

Lewis JG, Shand BI, Frampton CM, Elder PA.

Clin Biochem. 2007 Jul;40(11):828-34. Epub 2007 Apr 19.

PMID:
17498680
29.

Biovariability of plasma adiponectin.

Shand B, Elder P, Scott R, Frampton C, Willis J.

Clin Chem Lab Med. 2006;44(10):1264-8.

PMID:
17032140
30.

Plasma variation of corticosteroid-binding globulin and sex hormone-binding globulin.

Lewis JG, Möpert B, Shand BI, Doogue MP, Soule SG, Frampton CM, Elder PA.

Horm Metab Res. 2006 Apr;38(4):241-5.

PMID:
16700005
31.

Comparative effects of enzogenol and vitamin C supplementation versus vitamin C alone on endothelial function and biochemical markers of oxidative stress and inflammation in chronic smokers.

Young JM, Shand BI, McGregor PM, Scott RS, Frampton CM.

Free Radic Res. 2006 Jan;40(1):85-94. Erratum in: Free Radic Res. 2007 Jan;41(1):121.

PMID:
16298763
32.

The postprandial state does not impair endothelial function in women with type 2 diabetes irrespective of glycaemic control.

Strey CH, Young J, Collier M, Florkowski CM, Shand BI, Scott RS.

Diabetologia. 2004 Oct;47(10):1838-46. Epub 2004 Oct 22.

PMID:
15502920
33.
34.

Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance.

Shand BI, Scott RS, Elder PA, George PM.

Diabetes Obes Metab. 2003 Sep;5(5):349-53.

PMID:
12940874
35.

Pilot study on the clinical effects of dietary supplementation with Enzogenol, a flavonoid extract of pine bark and vitamin C.

Shand B, Strey C, Scott R, Morrison Z, Gieseg S.

Phytother Res. 2003 May;17(5):490-4.

PMID:
12748985
36.

Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.

Shand BI, Lewis JG, Elder PA, Agarwal M.

Clin Nephrol. 2002 Oct;58(4):321-4. No abstract available.

PMID:
12400851
37.

Hemorheological investigations in patients with polycystic kidney disease.

Shand BI.

Clin Hemorheol Microcirc. 2002;27(1):13-6.

PMID:
12237486
38.
39.

A comparison of post-prandial changes in flow-mediated dilatation in patients with type 2 diabetes with and without macroalbuminuria.

Shand BI, Scott RS, Florkowski CM, Reynolds, Ikram H.

Diabetes Nutr Metab. 2001 Aug;14(4):201-6.

PMID:
11716289
40.
41.

Effect of lacidipine on blood pressure, vasoactive hormones, and haemorheology in elderly patients with essential hypertension.

Shand BI, Gilchrist NL, Nicholls MG, Caesar M.

J Hum Hypertens. 2000 Jul;14(7):473-5. No abstract available.

PMID:
10918554
42.
43.
44.

Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.

Bailey RR, Shand BI, Smith AH, Robson RA, Lynn KL.

Clin Nephrol. 1997 Oct;48(4):224-9.

PMID:
9352156
45.

Has the ESR gone past its 'use by date'?

Shand B.

N Z Med J. 1997 Aug 22;110(1050):322. No abstract available.

PMID:
9315036
46.

Oral vanadyl sulphate does not affect blood cells, viscosity or biochemistry in humans.

Fawcett JP, Farquhar SJ, Thou T, Shand BI.

Pharmacol Toxicol. 1997 Apr;80(4):202-6.

PMID:
9140141
47.

Fingernail creatinine as a determinant of the duration of renal failure.

Shand BI, Bailey MA, Bailey RR.

Clin Nephrol. 1997 Feb;47(2):135-6. No abstract available.

PMID:
9049468
48.

Fluvastatin for dyslipoproteinemia, with or without concomitant chronic renal insufficiency.

Lintott CJ, Scott RS, Bremer JM, Shand BI.

Am J Cardiol. 1995 Jul 13;76(2):97A-101A.

PMID:
7604809
49.

Effect of enalapril on erythrocytosis in hypertensive patients with renal disease.

Shand BI, Bailey RR, Lynn KL, Robson RA.

Blood Press. 1995 Jul;4(4):238-40.

PMID:
7496563
50.

Effect of enalapril on hemorheology in hypertensive patients with renal disease.

Shand BI, Bailey RR, Lynn KL, Robson RA.

Clin Exp Hypertens. 1995 May;17(4):689-700.

PMID:
7795581

Supplemental Content

Support Center